Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
3(60.0%)
N/A
1(20.0%)
Phase 4
1(20.0%)
5Total
Phase 1(3)
N/A(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT04694495Completed

HPV Infection and Genital Microecology of Childbearing-age Female in China: A Cohort and Multicenter Study

Role: collaborator

NCT03207100Not ApplicableCompleted

Analgesia-first Minimal Sedation for Spontaneous Intracerebral Hemorrhage Early Antihypertensive Treatment

Role: collaborator

NCT03107078Phase 4Unknown

Using A Novel Classification System in Intravenous GCs Therapy of TAO: A Multi-central, Randomized, Open, Superior Trial

Role: collaborator

NCT02831075Phase 1Unknown

A Clinical Study Using Adipose-derived Stem Cells for Diabetic Foot

Role: collaborator

NCT02796079Phase 1Unknown

A Clinical Study Using Autologous Bone Marrow Stem Cell for Diabetes Related Vascular Complications

Role: collaborator

NCT02834858Phase 1Unknown

Umbilical Cord Mesenchymal Stem Cells Infusion for Diabetes Related Vascular Complications

Role: collaborator

All 6 trials loaded